DWA
GWPH

Dorsey Wright & Associates’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Dorsey Wright & Associates’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-29,709
Closed -$2.89M – 347
2018
Q4 		$2.89M Sell
29,709
-11,425
-28% -$1.5M 0.87% 62
2018
Q3 		$7.11M Buy
+41,134
New +$5.93M 1.29% 22

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dorsey Wright & Associates's GWPH Position: Q1 2019 in Review

Dorsey Wright & Associates sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2019, closing a stake of 29,709 shares — an estimated $2.89M sold.

Dorsey Wright & Associates first reported a position in GWPH in Q3 2018 and held it in 2 quarters. The position peaked at $7.11M in Q3 2018. 320 funds tracked by Wall St. Rank hold GWPH as of Q1 2019.

  • Dorsey Wright & Associates reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2019 after selling out during the quarter.
  • Dorsey Wright & Associates sold 29,709 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2019, an estimated $2.89M.
  • Dorsey Wright & Associates first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2018 and held it in 2 quarters.
  • Dorsey Wright & Associates's GW Pharmaceuticals Plc American Depositary Shares position peaked at $7.11M in Q3 2018.
  • 320 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2019.

Based on Dorsey Wright & Associates's 13F filing for Q1 2019, filed 4 Apr 2019.